Selected research
Industry Research
Medical Gamma Ray Imager Industry Research Report 2026
Market perspective
The global Medical Gamma Ray Imager market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Medical Gamma Ray Imager is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Medical Gamma Ray Imager is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Medical Gamma Ray Imager is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Medical Gamma Ray Imager include CardiArc, CLERAD, Crystal Photonics, DDD-Diagnostic, Digirad, Mediso, MIE America, Oncovision and Spectrum Dynamics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Medical Gamma Ray Imager market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Gamma Ray Imager Market by Company
CardiArc
CLERAD
Crystal Photonics
DDD-Diagnostic
Digirad
Mediso
MIE America
Oncovision
Spectrum Dynamics
Medical Gamma Ray Imager Segment by Type
Single Detector
Dual Detector
Medical Gamma Ray Imager Segment by Application
Hospital
Nursing Home
Red Cross
Other
Medical Gamma Ray Imager Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Gamma Ray Imager market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Gamma Ray Imager and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Gamma Ray Imager.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Gamma Ray Imager manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Gamma Ray Imager by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Gamma Ray Imager in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Detector
- Dual Detector
Applications
- Hospital
- Nursing Home
- Red Cross
- Other
Companies covered
- CardiArc
- CLERAD
- Crystal Photonics
- DDD-Diagnostic
- Digirad
- Mediso
- MIE America
- Oncovision
- Spectrum Dynamics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Gamma Ray Imager Market Size (2021-2032)
- 2.2.2 Global Medical Gamma Ray Imager Sales (2021-2032)
- 2.2.3 Global Medical Gamma Ray Imager Market Average Price (2021-2032)
- 2.3 Medical Gamma Ray Imager by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Single Detector
- 2.3.3 Dual Detector
- 2.4 Medical Gamma Ray Imager by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Nursing Home
- 2.4.4 Red Cross
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Gamma Ray Imager Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Gamma Ray Imager Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Medical Gamma Ray Imager Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Gamma Ray Imager Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Gamma Ray Imager Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Gamma Ray Imager, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Gamma Ray Imager, Product Type & Application
- 3.8 Global Manufacturers of Medical Gamma Ray Imager, Established Date
- 3.9 Global Medical Gamma Ray Imager Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CardiArc
- 4.1.1 CardiArc Company Information
- 4.1.2 CardiArc Business Overview
- 4.1.3 CardiArc Medical Gamma Ray Imager Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CardiArc Medical Gamma Ray Imager Product Portfolio
- 4.1.5 CardiArc Recent Developments
- 4.2 CLERAD
- 4.2.1 CLERAD Company Information
- 4.2.2 CLERAD Business Overview
- 4.2.3 CLERAD Medical Gamma Ray Imager Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CLERAD Medical Gamma Ray Imager Product Portfolio
- 4.2.5 CLERAD Recent Developments
- 4.3 Crystal Photonics
- 4.3.1 Crystal Photonics Company Information
- 4.3.2 Crystal Photonics Business Overview
- 4.3.3 Crystal Photonics Medical Gamma Ray Imager Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Crystal Photonics Medical Gamma Ray Imager Product Portfolio
- 4.3.5 Crystal Photonics Recent Developments
- 4.4 DDD-Diagnostic
- 4.4.1 DDD-Diagnostic Company Information
- 4.4.2 DDD-Diagnostic Business Overview
- 4.4.3 DDD-Diagnostic Medical Gamma Ray Imager Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 DDD-Diagnostic Medical Gamma Ray Imager Product Portfolio
- 4.4.5 DDD-Diagnostic Recent Developments
- 4.5 Digirad
- 4.5.1 Digirad Company Information
- 4.5.2 Digirad Business Overview
- 4.5.3 Digirad Medical Gamma Ray Imager Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Digirad Medical Gamma Ray Imager Product Portfolio
- 4.5.5 Digirad Recent Developments
- 4.6 Mediso
- 4.6.1 Mediso Company Information
- 4.6.2 Mediso Business Overview
- 4.6.3 Mediso Medical Gamma Ray Imager Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mediso Medical Gamma Ray Imager Product Portfolio
- 4.6.5 Mediso Recent Developments
- 4.7 MIE America
- 4.7.1 MIE America Company Information
- 4.7.2 MIE America Business Overview
- 4.7.3 MIE America Medical Gamma Ray Imager Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MIE America Medical Gamma Ray Imager Product Portfolio
- 4.7.5 MIE America Recent Developments
- 4.8 Oncovision
- 4.8.1 Oncovision Company Information
- 4.8.2 Oncovision Business Overview
- 4.8.3 Oncovision Medical Gamma Ray Imager Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Oncovision Medical Gamma Ray Imager Product Portfolio
- 4.8.5 Oncovision Recent Developments
- 4.9 Spectrum Dynamics
- 4.9.1 Spectrum Dynamics Company Information
- 4.9.2 Spectrum Dynamics Business Overview
- 4.9.3 Spectrum Dynamics Medical Gamma Ray Imager Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Spectrum Dynamics Medical Gamma Ray Imager Product Portfolio
- 4.9.5 Spectrum Dynamics Recent Developments
5 Global Medical Gamma Ray Imager Market Scenario by Region
- 5.1 Global Medical Gamma Ray Imager Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Gamma Ray Imager Sales by Region: 2021-2032
- 5.2.1 Global Medical Gamma Ray Imager Sales by Region: 2021-2026
- 5.2.2 Global Medical Gamma Ray Imager Sales by Region: 2027-2032
- 5.3 Global Medical Gamma Ray Imager Revenue by Region: 2021-2032
- 5.3.1 Global Medical Gamma Ray Imager Revenue by Region: 2021-2026
- 5.3.2 Global Medical Gamma Ray Imager Revenue by Region: 2027-2032
- 5.4 North America Medical Gamma Ray Imager Market Facts & Figures by Country
- 5.4.1 North America Medical Gamma Ray Imager Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Gamma Ray Imager Sales by Country (2021-2032)
- 5.4.3 North America Medical Gamma Ray Imager Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Gamma Ray Imager Market Facts & Figures by Country
- 5.5.1 Europe Medical Gamma Ray Imager Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Gamma Ray Imager Sales by Country (2021-2032)
- 5.5.3 Europe Medical Gamma Ray Imager Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Gamma Ray Imager Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Gamma Ray Imager Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Gamma Ray Imager Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Gamma Ray Imager Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Gamma Ray Imager Market Facts & Figures by Country
- 5.7.1 South America Medical Gamma Ray Imager Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Gamma Ray Imager Sales by Country (2021-2032)
- 5.7.3 South America Medical Gamma Ray Imager Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Medical Gamma Ray Imager Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Gamma Ray Imager Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Gamma Ray Imager Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Gamma Ray Imager Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Gamma Ray Imager Sales by Type (2021-2032)
- 6.1.1 Global Medical Gamma Ray Imager Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Medical Gamma Ray Imager Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Gamma Ray Imager Revenue by Type (2021-2032)
- 6.2.1 Global Medical Gamma Ray Imager Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Gamma Ray Imager Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Gamma Ray Imager Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Gamma Ray Imager Sales by Application (2021-2032)
- 7.1.1 Global Medical Gamma Ray Imager Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Medical Gamma Ray Imager Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Gamma Ray Imager Revenue by Application (2021-2032)
- 7.2.1 Global Medical Gamma Ray Imager Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Gamma Ray Imager Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Gamma Ray Imager Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Gamma Ray Imager Value Chain Analysis
- 8.1.1 Medical Gamma Ray Imager Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Gamma Ray Imager Production Mode & Process
- 8.2 Medical Gamma Ray Imager Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Gamma Ray Imager Distributors
- 8.2.3 Medical Gamma Ray Imager Customers
9 Global Medical Gamma Ray Imager Analyzing Market Dynamics
- 9.1 Medical Gamma Ray Imager Industry Trends
- 9.2 Medical Gamma Ray Imager Industry Drivers
- 9.3 Medical Gamma Ray Imager Industry Opportunities and Challenges
- 9.4 Medical Gamma Ray Imager Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst